Javed Butler

Isovolumic Contraction Velocity in Heart Failure with Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: The PROVE-HF Study.

G. Felker, J. Januzzi, Jonathan H. Ward, 2023, Journal of cardiac failure.

Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure.

Stephen J. Greene, Javed Butler, M. Kosiborod, 2024, The American journal of medicine.

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

D. Kitzman, V. Melenovský, D. Lewinski, 2024, The Lancet.

Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.

J. Lindenfeld, M. Metra, Javed Butler, 2024, Journal of the American College of Cardiology.

Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey

Anthony Hoovler, Javed Butler, Sanjiv J. Shah, 2024, BMC primary care.

Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy

P. Gouda, J. Januzzi, Justin A. Ezekowitz, 2024, Cardiovascular diabetology.

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.

J. Januzzi, Riccardo Perfetti, Justin A. Ezekowitz, 2024, Journal of the American College of Cardiology.

Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.

J. Prochaska, J. Januzzi, João Pedro Ferreira, 2024, Journal of the American College of Cardiology.

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.

D. Kitzman, S. Z. Abildstrom, B. Merkely, 2024, Journal of the American College of Cardiology.